FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Qualitest Pharmaceuticals HydrOXYzine Hydrochloride Tablets Recall

HydrOXYzine Hydrochloride Tablets, USP 25 mg, Rx only, 100 count (NDC 0603-3968-21), 5…

Qualitest Pharmaceuticals · Huntsville, AL

Risk level
Class III
Reported by FDA
Jul 22, 2015
Recall ID
D-1239-2015
Check your lot numberHow we source this data

Summary

Qualitest Pharmaceuticals recalled HydrOXYzine Hydrochloride Tablets starting Jun 29, 2015. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1239-2015 on Jul 22, 2015. Reason: Failed Tablet/Capsule Specifications; The identification codes on some tablets may be unreadable. Status: Terminated.

Why it was recalled

Failed Tablet/Capsule Specifications; The identification codes on some tablets may be unreadable

Product description

HydrOXYzine Hydrochloride Tablets, USP 25 mg, Rx only, 100 count (NDC 0603-3968-21), 500 count (NDC 0603-3968-28) and 1000 count (NDC 0603-3968-32) bottles, Manufactured for Qualitest Pharmaceuticals, Huntsville, AL

Lot numbers, UPCs & expiration codes

100 count (NDC 0603-3968-21); LOTS# T144F13A, T130G13B, T132G13A, exp date 6/15, T115D14A, exp date 3/16; 500 count (NDC 0603-3968-28), LOT# T144F13B exp date 6/15; and 1000 count (NDC 0603-3968-32); LOTS # T144F13C, T132G13B, exp date 6/15, T115D14B, exp date 3/16

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1239-2015
Classification
Class III
Status
Terminated
Recall initiated
Jun 29, 2015
FDA report date
Jul 22, 2015
Quantity
47,376 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Qualitest Pharmaceuticals

Original FDA data

Every field from FDA enforcement report D-1239-2015, exactly as published.

Show all FDA fields
City
Huntsville
State
AL
Status
Terminated
Country
United States
Event ID
71646
Address
120 Vintage Dr NE
Code information
100 count (NDC 0603-3968-21); LOTS# T144F13A, T130G13B, T132G13A, exp date 6/15, T115D14A, exp date 3/16; 500 count (NDC 0603-3968-28), LOT# T144F13B exp date 6/15; and 1000 count (NDC 0603-3968-32); LOTS # T144F13C, T132G13B, exp date 6/15, T115D14B, exp date 3/16
Postal code
35811-8216
Report date
Jul 22, 2015
Product type
Drugs
Recall number
D-1239-2015
Classification
Class III
Recalling firm
Qualitest Pharmaceuticals
Product quantity
47,376 bottles
Termination date
Oct 23, 2016
Reason for recall
Failed Tablet/Capsule Specifications; The identification codes on some tablets may be unreadable
Voluntary / mandated
Voluntary: Firm initiated
Product description
HydrOXYzine Hydrochloride Tablets, USP 25 mg, Rx only, 100 count (NDC 0603-3968-21), 500 count (NDC 0603-3968-28) and 1000 count (NDC 0603-3968-32) bottles, Manufactured for Qualitest Pharmaceuticals, Huntsville, AL
Distribution pattern
Nationwide
Recall initiation date
Jun 29, 2015
Initial firm notification
Letter
Center classification date
Jul 15, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1239-2015, published Jul 22, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls